Surfactant replacement therapy as promising treatment for COVID-19: an updated narrative review

Patients with COVID-19 exhibit similar symptoms to neonatal respiratory distress syndrome. SARS-CoV-2 spike protein has been shown to target alveolar type 2 lung cells which synthesize and secrete endogenous surfactants leading to acute respiratory distress syndrome in some patients. This was proven...

Descripción completa

Detalles Bibliográficos
Autores principales: Khudadah, Khaled, Ramadan, Alaa, Othman, Ahmed, Refaey, Neveen, Elrosasy, Amr, Rezkallah, Ayoub, Heseba, Toka, Moawad, Mostafa Hossam El Din, Mektebi, Ammar, Elejla, Sewar A, Abouzid, Mohamed, Abdelazeem, Basel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2023
Materias:
Pharmacology & Toxicology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412525/
https://www.ncbi.nlm.nih.gov/pubmed/37497603
http://dx.doi.org/10.1042/BSR20230504

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412525/
https://www.ncbi.nlm.nih.gov/pubmed/37497603
http://dx.doi.org/10.1042/BSR20230504

Ejemplares similares